Effect of Prophylactic Treatment on Suicide Risk in Patients with Major Affective Disorders: Data from a Randomized Prospective Trial

Pharmacopsychiatry

Volumn 29, Issue 3, 1996, Pages 103-107

  Thies Flechtner, K ^a   Muller Oerlinghausen B ^a   Seibert, W ^b   Walther, A ^c   Greil, W ^c  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CARBAMAZEPINE; CLOZAPINE; IMIPRAMINE; LITHIUM; PERAZINE; PIPAMPERONE; TRANYLCYPROMINE; TRIFLUOPERAZINE;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUICIDE;

ADOLESCENT; ADULT; AFFECTIVE DISORDERS, PSYCHOTIC; AGED; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIMANIC AGENTS; CARBAMAZEPINE; CENTRAL NERVOUS SYSTEM AGENTS; FOLLOW-UP STUDIES; HUMANS; LITHIUM; MIDDLE AGED; PROSPECTIVE STUDIES; RISK; SUICIDE;

EID: 0029982088     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979553     Document Type: Article

References (39)

1. Angst, J., H. H. Stassen: Verlaufsaspekte affektiver Psychosen: Suizide, Rückfallrisiko im Alter. In: Huber, G. (Hrsg.): Fortschritte in der Psychosenforschung. Schattauer, Stuttgart, New York, (1987) 145-161
2. Bagley, C., S. Jacobson, A. Rehin: Completed suicide: a taxonomic analysis of clinical and social data. Psychol. Med. 6 (1976) 429-438
3. Berglund, M., K. Nilsson: Mortality in severe depression. A prospective study including 103 suicides. Act. Psychiatr. Scand. 76 (1988) 372-380
4. Black, D. W., G. Warrack, G. Winokur: The Iowa record-linkage study I. Suicides and accidental deaths among psychiatric patients. Arch. Gen. Psychiatry 42 (1985) 82-89
5. Black, D. W., G. Winokur, A. Nasrallah: Suicide in subtypes of major affective disorder. Arch. Gen. Psychiatry 44 (1987) 878-880
6. Black, D. W., G. Winokur, A. Nasrallah: Effect of psychosis on suicide risk in 1,593 patients with unipolar and bipolar affective disorders. Am. J. Psychiatry 147 (1988) 849-852
7. Black, D. W., G. Winokur, E. Mohandoss, R. F. Woolson, A. Nasrallah: Does treatment influence mortality in depressives? A follow-up of 1076 patients with affective disorders. Ann. Clin. Psychiatry 1 (1989) 165-173
8. Coppen, A., H. Standish-Barry, J. Bailey, G. Houston, P. Silcocks, C. Hermon: Long-term lithium and mortality. Lancet 335 (1990) 1347
9. Coppen, A., H. Standish-Barry, J. Bailey, G. Houston, P. Silcocks, C. Hermon: Does lithium reduce the mortality of recurrent mood disorders? J. Affect. Dis. 23 (1991) 1-7
10. Coppen, A: Depression as a lethal disease, prevention strategies. J. Clin. Psychiat. 55 (1994) 37-45
11. Fawcett, J., W. Scheftner, D. Clark, D. Hedeker, R. Gibbons, W. Coryell: Clinical predictors of suicide in patients with major affective disorders: a controlled prospective study. Am. J. Psychiatry 144 (1987) 35-40
12. Fawcett, J., W. Scheftner, L. Fogg, D. Clark, M. Young, D. Hedeker, R. Gibbons: Time-related predictors of suicide in major affective disorder. Am. J. Psychiatry 147 (1990) 1189-1194
13. Felber, W., A. Kyber: Suizide and Parasuizide (Suizidversuche) während und außerhalb einer Lithiumprophylaxe. In: Ziele und Ergebnisse der medikamentösen Prophylaxe affektiver Psychosen. Edited by Müller-Oerlinghausen, B., A. Berghöfer. G. Thieme, Stuttgart (1994), pp. 53-59
14. Glen, A. I. M., M. Dodd, E. B. Hulme, N. Kreitman: Mortality on lithium. Neuropsychobiology 5 (1979) 167-173
15. Greil, W., M. Haag, D. Huber, S. Schmidt: Maintenance treatment in affective disorders: Overview and design of a collaborative study. Pharmacopsychiat. 19 (1986) 167-169
16. Greil, W., W. Ludwig-Mayerhofer, B. Steller, A. Czernik, H. Giedke, B. Müller-Oerlinghausen, M. Osterheider, G. A. Rudolf, H. Sauer, J. Tegeler, T. Wetterling: The recruitment process for a multicenter study on the longterm prophylactic treatment of affective disorders. J. Affect. Dis. 28 (1993) 257-265
17. Greil, W., W. Ludwig-Mayerhofer, B. Steller, A. Czernik, H. Giedke, B. Müller-Oerlinghausen, M. Osterheider, G. A. Rudolf, H. Sauer, J. Tegeler, T. Wetterling: Lithium- oder Carbamazepinprophylaxe bei affektiven Psychosen? Ergebnisse einer kontrollierten, multizentrischen Studie. In: Ziele und Ergebnisse der medikamentösen Prophylaxe affektiver Psychosen. Edited by Müller-Oerlinghausen, B., A. Berghöfer. G. Thieme, Stuttgart (1994), pp. 113-119
18. Guze, S., E. Robins: Suicide and primary affective disorders. Brit. J. Psychiatry 117 (1970) 437-438
19. Hanus, K., M. Zapletalek: Suicidal activity of patients with affective disorders in the course of lithium prophylaxis. Ceskoslovenska Psychiatrie 80 (1984) 97-100
20. Jamison, K. R.: Suicide and bipolar disorders. Ann. N. Y. Acad. Sci. 487 (1986) 301-315
21. Johnson, F. N.: The psychopharmacology of lithium. In: The psychopharmacology of lithium. Edited by F. N. Johnson. London, MacMillan Press (1984)
22. Lepkifker, W., N. Horesh, S. Floru: Long-term lithium prophylaxis in recurrent unipolar depression. A controversial indication? Acta psychiat. Belg. 85 (1985) 434-443
23. Lester, D.: Suicidal behavior in bipolar and unipolar affective disorders: a meta-analysis. J. Affect. Disord. 27 (1993) 117-121
24. Modestin, J., F. Schwarzenbach: Effect of psychopharmacotherapy on suicide risk in discharged psychiatric inpatients. Acta Psychiatr. Scand. 85 (1992) 173-175
25. Müller-Oerlinghausen, B., B. Ahrens, E. Grof, P. Grof, G. Lenz, M. Schou, C. Simhandl, K. Thau, J. Volk, R. Wolf, T. Wolf: The effect of long-term lithium treatment: on the mortality of patients with manic-depressive and schizoaffective illness. Acta Psychiatr. Scand. 86 (1992a) 218-222
26. Müller-Oerlinghausen, B., B. Müser-Causemann, J. Volk: Suicides and parasuicides in a high-risk group on and off lithium long-term medication. J. Affect. Disord. 25 (1992b) 261-270
27. Murphy, G. E.: On suicide prediction and prevention. Arch. Gen. Psychiatry 40 (1983) 343-344
28. Norton, B., L. J. Whalley: Mortality of a lithium treated population. Brit. J. Psychiatry 145 (1984) 277-282
29. Ottosson, J. O.: The suicidal patient - can the psychiatrist prevent his suicide? In: Origin, prevention and treatment of affective disorders. Edited by M. Schou, E. Strömgren. London, New York, San Francisco, Academic Press, (1979) pp. 257-267
30. Pokorny, A. D.: Prediction of suicide in psychiatric patients. Arch. Gen. Psychiatry 40 (1983) 249-257
31. Price, L. H. D. S. Charney, P. L. Delgado, G. R. Heninger: Lithium and serotonin function: implications for the serotonin hypothesis of depression. Psychopharmacology 100 (1990) 3-12
32. Price, L. H., G. R. Heninger: Lithium in the treatment of mood disorders. N. Engl. J. Med. 331 (1994) 591-598
33. Rouillon, F., R. Phillips, D. Serrurier et al.: Recurrence of unipolar depression efficacy of maprotiline. Encephale 15 (1989) 527-534
34. Roy, A.: Risk factors for suicide in psychiatric patients. Arch. Gen. Psychiatry 39 (1982) 1089-1096
35. Schou, M., A. Weeke: Did manic-depressive patients who committed suicide receive prophylactic or continuation treatment at the time? Brit. J. Psychiatry 153 (1988) 324-327
36. Tsuang, M. T., R. F. Woolson: Excess mortality in schizophrenia and affective disorders: Do suicides and accidental deaths solely account for this excess? Arch. Gen. Psychiatry 35 (1978) 1181-1185
37. Vestergaard, P., J. Aagaard: Five-year mortality in lithium-treated manic-depressive patients, J. Affect. Dis. 21 (1991) 33-38
38. Weeke, A.: Causes of death in manic-depressives. In: M. Schou and E. Strömgren (Ed.), Origin, prevention and treatment of affective disorders. Academic Press, London, New York, San Francisco, pp. 289-299
39. Wickham, E. A., J. V. Reed: Lithium for the control of aggressive and self-mutilating behaviour. Int. Clin. Psychopharmacol. 2 (1987) 181-190